3D Screen Printing: Breakthrough Solutions For Patient-Centric Therapies

Explore the transformative role of 3D screen printing in pharmaceutical manufacturing, a breakthrough technology that addresses the scalability and formulation limitations of traditional 3D printing methods. Unlike earlier techniques—such as laser-based or nozzle extrusion printing—that suffer from high costs, active pharmaceutical ingredient (API) degradation, and limited production capacity, 3D screen printing offers a precise additive manufacturing approach. This method allows for the production of complex, multi-functional tablets and microtablets with customizable release profiles, enabling more effective, patient-centric therapies.

A primary advantage of 3D screen printing is its exceptional control over drug release timing and mechanisms. While conventional tableting often struggles to achieve precision in layered or timed-release formulations, 3D screen printing builds each tablet layer by layer, allowing for immediate, extended, sequential, or delayed release—all within a single dosage form. This flexibility allows multiple APIs and mechanisms to coexist in one tablet, optimizing therapeutic impact and simplifying treatment regimens.

The webinar showcases how this technology can enhance pharmacokinetics, reduce drug side effects, and minimize API quantities, all while remaining cost-effective. Importantly, 3D screen printing supports both small-scale R&D and high-volume commercial manufacturing, with the potential to produce up to 1.5 million units daily.

Additionally, it opens new pathways for intellectual property protection by enabling the design of unique, differentiated dosage forms. Gain insights into the commercial and clinical potential of this cutting-edge pharmaceutical production method, which is poised to reshape how personalized medicine is developed and delivered.